There was a 79% rise in pharma M&A activity last year, and a large part of that was driven by a single drugGLP-1, says Helen Johnson, Baker McKenzie M&A partner based in London
Molecular alterations and emerging targets in castration resistant prostate cancer
The SCN remains isolated from the synchronizing activity of the glucocorticoids, a phenomenon which has historically been attributed to a lack of GR expression in this brain region 9
To get a definitive answer about whether you are covered, please consult your healthcare provider or your insurance plan benefits document
John Wiley & sons Ltd and the Institute of Food Technologists, Chicago, pp 255283 E I, Vieira JDG, Amaral AC (2015) Principles, techniques, and applications of biocatalyst immobilization for industrial application